Product Code: ETC4471677 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 |
The Ghana Cardiac Marker Testing Market is witnessing growth propelled by factors such as cardiovascular disease prevalence, aging population, and healthcare infrastructure development. Cardiac marker testing, including biomarker assays for detecting heart-related conditions such as myocardial infarction and heart failure, plays a crucial role in diagnosing and monitoring cardiac health in Ghana healthcare system.
The increasing prevalence of cardiovascular diseases and the need for early diagnosis are driving the growth of the cardiac marker testing market in Ghana. Technological advancements in diagnostic techniques and rising healthcare expenditure are also significant drivers.
Challenges in the cardiac marker testing market in Ghana revolve around the limited availability of advanced diagnostic technologies and trained healthcare professionals, particularly in rural areas. Additionally, cost constraints and reimbursement issues may hinder widespread adoption of cardiac marker testing services.
Government interventions in the cardiac marker testing market may aim to improve healthcare access, early disease detection, and patient outcomes. Policies might include investments in healthcare infrastructure, medical equipment, and training programs to expand the availability of cardiac marker testing services in hospitals, clinics, and community health centers. Additionally, the government may support initiatives to develop clinical guidelines and protocols for the use of cardiac biomarkers in diagnosing and managing cardiovascular diseases. Capacity-building programs for healthcare professionals, laboratory technicians, and medical researchers on cardiac marker testing techniques, interpretation, and patient care may also be promoted to enhance healthcare quality and effectiveness.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ghana Cardiac Marker Testing Market Overview |
3.1 Ghana Country Macro Economic Indicators |
3.2 Ghana Cardiac Marker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Ghana Cardiac Marker Testing Market - Industry Life Cycle |
3.4 Ghana Cardiac Marker Testing Market - Porter's Five Forces |
3.5 Ghana Cardiac Marker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Ghana Cardiac Marker Testing Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 Ghana Cardiac Marker Testing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 Ghana Cardiac Marker Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ghana Cardiac Marker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Ghana |
4.2.2 Growing awareness about the importance of early detection of cardiac markers |
4.2.3 Technological advancements in cardiac marker testing methods |
4.3 Market Restraints |
4.3.1 Limited access to advanced healthcare facilities in certain regions of Ghana |
4.3.2 High cost associated with cardiac marker testing procedures |
4.3.3 Lack of skilled healthcare professionals in interpreting cardiac marker test results |
5 Ghana Cardiac Marker Testing Market Trends |
6 Ghana Cardiac Marker Testing Market, By Types |
6.1 Ghana Cardiac Marker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Ghana Cardiac Marker Testing Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Ghana Cardiac Marker Testing Market Revenues & Volume, By Reagents and Kits, 2021-2031F |
6.1.4 Ghana Cardiac Marker Testing Market Revenues & Volume, By Instruments, 2021-2031F |
6.2 Ghana Cardiac Marker Testing Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 Ghana Cardiac Marker Testing Market Revenues & Volume, By Troponin I and T, 2021-2031F |
6.2.3 Ghana Cardiac Marker Testing Market Revenues & Volume, By Creatine kinase-MB(CK-MB), 2021-2031F |
6.2.4 Ghana Cardiac Marker Testing Market Revenues & Volume, By Natriuretic peptide (Bnp Or Nt-Probnp), 2021-2031F |
6.2.5 Ghana Cardiac Marker Testing Market Revenues & Volume, By Myoglobin, 2021-2031F |
6.2.6 Ghana Cardiac Marker Testing Market Revenues & Volume, By High-sensitivity C-reactive protein(hs-CRP), 2021-2031F |
6.2.7 Ghana Cardiac Marker Testing Market Revenues & Volume, By Other Cardiac Biomarkers, 2021-2031F |
6.3 Ghana Cardiac Marker Testing Market, By Disease |
6.3.1 Overview and Analysis |
6.3.2 Ghana Cardiac Marker Testing Market Revenues & Volume, By Myocardial Infarction, 2021-2031F |
6.3.3 Ghana Cardiac Marker Testing Market Revenues & Volume, By Congestive Heart Failure, 2021-2031F |
6.3.4 Ghana Cardiac Marker Testing Market Revenues & Volume, By Acute Coronary Syndrome, 2021-2031F |
6.3.5 Ghana Cardiac Marker Testing Market Revenues & Volume, By Atherosclerosis, 2021-2031F |
6.3.6 Ghana Cardiac Marker Testing Market Revenues & Volume, By Ischemia, 2021-2031F |
6.4 Ghana Cardiac Marker Testing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Ghana Cardiac Marker Testing Market Revenues & Volume, By Laboratory Testing Facilities, 2021-2031F |
6.4.3 Ghana Cardiac Marker Testing Market Revenues & Volume, By Point-Of-Care Testing Facilities, 2021-2031F |
6.4.4 Ghana Cardiac Marker Testing Market Revenues & Volume, By Academic Institutions, 2021-2031F |
7 Ghana Cardiac Marker Testing Market Import-Export Trade Statistics |
7.1 Ghana Cardiac Marker Testing Market Export to Major Countries |
7.2 Ghana Cardiac Marker Testing Market Imports from Major Countries |
8 Ghana Cardiac Marker Testing Market Key Performance Indicators |
8.1 Average turnaround time for cardiac marker test results |
8.2 Number of healthcare facilities offering cardiac marker testing services in Ghana |
8.3 Rate of adoption of new cardiac marker testing technologies |
9 Ghana Cardiac Marker Testing Market - Opportunity Assessment |
9.1 Ghana Cardiac Marker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Ghana Cardiac Marker Testing Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 Ghana Cardiac Marker Testing Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.4 Ghana Cardiac Marker Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ghana Cardiac Marker Testing Market - Competitive Landscape |
10.1 Ghana Cardiac Marker Testing Market Revenue Share, By Companies, 2024 |
10.2 Ghana Cardiac Marker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |